Loading
Latest filing published 11 May 2026 for LAKEFRONT BIOTHERAPEUTICS, €236k. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Cox Aaron on record concern Lakefront Biotherapeutics. In total, 5 filings cover trades dated from 22 August 2025 to 7 May 2026.
Purchases make up the whole of the open-market record (5 purchases, €473k). The totals do not cover 3 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2026: 4 purchases and no sales on the market.
The newest entry dates from 11 May 2026: an open-market purchase of €236k, in Lakefront Biotherapeutics. Typically, a trade is published a median of 11 days after it takes place. The regulation allows three business days to notify a trade (MAR article 19). These figures are compiled from regulatory filings published by FSMA. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations